
Baxter International BAX
$ 19.94
1.06%
Quarterly report 2025-Q3
added 11-04-2025
Baxter International Total Current Liabilities 2011-2026 | BAX
Annual Total Current Liabilities Baxter International
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.51 B | 6.5 B | 4.74 B | 4.24 B | 3.33 B | 3.23 B | 2.84 B | 2.82 B | 2.74 B | 5.75 B | 6.04 B | 5.91 B | 4.76 B | 4.86 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 6.51 B | 2.74 B | 4.59 B |
Total Current Liabilities of other stocks in the Medical instruments industry
| Issuer | Total Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
12.6 K | - | - | $ 810 M | ||
|
Luminex Corporation
LMNX
|
87.5 M | - | - | $ 1.75 B | ||
|
Akers Biosciences, Inc.
AKER
|
1.53 M | - | -9.52 % | $ 20.6 M | ||
|
ICU Medical
ICUI
|
556 M | $ 149.15 | -0.59 % | $ 3.64 B | ||
|
Repro Med Systems
KRMD
|
4.45 M | $ 5.36 | -1.65 % | $ 244 M | ||
|
Antares Pharma, Inc.
ATRS
|
63.2 M | - | - | $ 955 M | ||
|
Cantel Medical Corp.
CMD
|
179 M | - | -1.18 % | $ 3.4 B | ||
|
CRH Medical Corporation
CRHM
|
11.8 M | - | - | $ 282 M | ||
|
Hill-Rom Holdings, Inc.
HRC
|
952 M | - | -0.05 % | $ 10.3 B | ||
|
Varian Medical Systems, Inc.
VAR
|
1.85 B | - | -0.02 % | $ 16.3 B | ||
|
OraSure Technologies
OSUR
|
33.5 M | $ 2.76 | -1.08 % | $ 205 M | ||
|
Ekso Bionics Holdings
EKSO
|
7.54 M | $ 8.74 | 4.14 % | $ 176 M | ||
|
AtriCure
ATRC
|
73.4 M | $ 36.51 | -1.19 % | $ 1.71 B | ||
|
Haemonetics Corporation
HAE
|
578 M | $ 66.12 | 0.23 % | $ 3.33 B | ||
|
electroCore
ECOR
|
8.12 M | $ 6.56 | -7.61 % | $ 36.2 K | ||
|
AngioDynamics
ANGO
|
76.2 M | $ 10.33 | 3.51 % | $ 422 M | ||
|
InfuSystem Holdings
INFU
|
14.5 M | $ 8.25 | 2.61 % | $ 170 M | ||
|
STERIS plc
STE
|
1.02 B | $ 261.51 | -0.05 % | $ 25.8 B | ||
|
The Cooper Companies
COO
|
1.11 B | $ 80.56 | 0.24 % | $ 16 B | ||
|
Masimo Corporation
MASI
|
618 M | $ 135.1 | -0.85 % | $ 7.2 B | ||
|
Harvard Bioscience
HBIO
|
26.5 M | $ 0.51 | -5.5 % | $ 21.6 M | ||
|
Glaukos Corporation
GKOS
|
74 M | $ 118.29 | -0.56 % | $ 5.73 B | ||
|
Merit Medical Systems
MMSI
|
216 M | $ 81.27 | 1.28 % | $ 4.73 B | ||
|
Isoray
ISR
|
18.2 M | - | 0.03 % | $ 108 M | ||
|
iRhythm Technologies
IRTC
|
111 M | $ 152.4 | 2.29 % | $ 4.75 B | ||
|
LeMaitre Vascular
LMAT
|
30.6 M | $ 84.52 | 0.79 % | $ 1.9 B | ||
|
Intuitive Surgical
ISRG
|
1.75 B | $ 503.25 | -0.85 % | $ 179 B | ||
|
NeuroMetrix
NURO
|
1.01 M | - | 5.05 % | $ 9.02 M | ||
|
Utah Medical Products
UTMD
|
4.71 M | $ 61.3 | -0.57 % | $ 222 M | ||
|
Microbot Medical
MBOT
|
3.79 M | $ 1.82 | -2.16 % | $ 18.6 M | ||
|
Nephros
NEPH
|
2.11 M | $ 4.31 | -1.82 % | $ 44.8 M | ||
|
Milestone Scientific
MLSS
|
3.74 M | $ 0.3 | -0.5 % | $ 23.9 M | ||
|
Envista Holdings Corporation
NVST
|
879 M | $ 23.05 | -1.45 % | $ 3.97 B | ||
|
Pro-Dex
PDEX
|
14.6 M | $ 39.41 | 0.01 % | $ 130 M | ||
|
Predictive Oncology
POAI
|
3.59 M | - | - | $ 31.1 M | ||
|
Pulse Biosciences
PLSE
|
6.71 M | $ 13.67 | 0.37 % | $ 657 M | ||
|
Becton, Dickinson and Company
BDX
|
8.31 B | $ 202.08 | 0.49 % | $ 58.1 B | ||
|
Repligen Corporation
RGEN
|
165 M | $ 150.45 | -3.79 % | $ 8.38 M | ||
|
ResMed
RMD
|
689 M | $ 252.03 | -2.17 % | $ 36.8 B | ||
|
BioLife Solutions
BLFS
|
32.7 M | $ 22.01 | -2.52 % | $ 1.01 B | ||
|
Stereotaxis
STXS
|
13.2 M | $ 2.25 | -3.43 % | $ 182 M | ||
|
Retractable Technologies
RVP
|
8.78 M | $ 0.69 | 0.36 % | $ 20.7 M | ||
|
STAAR Surgical Company
STAA
|
70.3 M | $ 18.85 | -0.48 % | $ 926 M | ||
|
Teleflex Incorporated
TFX
|
649 M | $ 104.3 | -1.12 % | $ 4.89 B | ||
|
West Pharmaceutical Services
WST
|
550 M | $ 228.04 | -1.98 % | $ 16.6 B | ||
|
DENTSPLY SIRONA
XRAY
|
1.59 B | $ 12.36 | 0.73 % | $ 2.51 B |